Rich S S, Orson F M, Rich R R
J Exp Med. 1977 Nov 1;146(5):1221-33. doi: 10.1084/jem.146.5.1221.
Previous studies have shown that alloantigen-activated spleen T cells produce a soluble factor which suppresses mixed lymphocyte reaction proliferative responses, and that the interaction between suppressor and responder cells is controlled by genes of the H-2 complex. However a defect in the expression of suppressor activity was identified in the mouse strain C57BL/6J. Factor prepared from alloactivated B6 spleen cells failed to suppress MLR responses of syngeneic or H-2 compatible responder cells. Unimpaired suppressor factor production by other H-2 (b) strains and failure of suppressor factor production by a B6 congenic strain, B6.C-H-2(d) isolated the defective gene to the non-H-2 portion of the genome. In addition, the defect appeared to be related specifically to inability to produce an active factor, while the capacity to respond to suppressor molecules was unimpaired. The genetic character of the non-H-2 gene action was identified in F1 hybrid studies. Initially F(1) hybrids of the nondefective histoincompatible strains were studied. Suppressor factor from F1 cells suppressed the responses of both parental strains, and parental factors each suppressed the response of F(1) cells. Adsorption of F(1) factor with Con A-activated thymocytes of either parental strain removed suppressor activity specific for that strain, leaving activity against the other parental strain intact. The data support cedominant expression and production of distinct, parental H-2 haplotype-specific suppressor molecules by F(1) suppressor cells. An F(1) hybrid of the defective B6 strain with nondefective BALB/c produced suppressor factor which was also capable of suppressing both parental strains. Production of a suppressive B6-reactive factor by F(1) cells was verified by adsorption studies. Thus it appears that non-H-2 genes of the BALB/c parent acted in a genetically dominant fashion to provide the function required for expression of B6 suppressor molecules. We conclude that multiple genes control the expression of alloactivated suppressor cell activity, with at least one gene mapped to the I-C subregion of the murine major histocompatibility complex and one or more genes mapped to the non-H-2 gene complement.
先前的研究表明,同种异体抗原激活的脾脏T细胞会产生一种可溶性因子,该因子可抑制混合淋巴细胞反应增殖应答,并且抑制细胞与应答细胞之间的相互作用受H-2复合体基因的控制。然而,在小鼠品系C57BL/6J中发现了抑制活性表达的缺陷。从同种异体激活的B6脾细胞制备的因子未能抑制同基因或H-2相容应答细胞的混合淋巴细胞反应应答。其他H-2(b)品系的抑制因子产生未受损害,而B6同源品系B6.C-H-2(d)的抑制因子产生失败,将缺陷基因定位到基因组的非H-2部分。此外,该缺陷似乎与无法产生活性因子特别相关,而对抑制分子的应答能力未受损害。非H-2基因作用的遗传特征在F1杂交研究中得以确定。最初研究了非缺陷组织不相容品系的F(1)杂种。来自F1细胞的抑制因子抑制了两个亲本品系的应答,并且每个亲本品系的因子都抑制了F(1)细胞的应答。用任一亲本品系的Con A激活的胸腺细胞吸附F(1)因子,去除了对该品系特异的抑制活性,而对另一亲本品系的活性保持完整。这些数据支持F(1)抑制细胞以共显性方式表达和产生不同的、亲本品系H-2单倍型特异性抑制分子。缺陷型B6品系与非缺陷型BALB/c的F(1)杂种产生的抑制因子也能够抑制两个亲本品系。通过吸附研究证实了F(1)细胞产生具有抑制作用的B6反应性因子。因此,似乎BALB/c亲本品系的非H-2基因以遗传显性方式发挥作用,以提供表达B6抑制分子所需的功能。我们得出结论,多个基因控制同种异体激活的抑制细胞活性的表达,其中至少一个基因定位于小鼠主要组织相容性复合体的I-C亚区,一个或多个基因定位于非H-2基因互补区。